New York
T:
+1 212 848 8244
F:
+1 646 848 8244
Add to Outlook
|
Danielle
Carbone
Partner
Education
The American University, Washington College of Law, J.D., 1988
Boston College, B.A., 1983, magna cum laude
Practice
Danielle Carbone is a partner in the Capital Markets Group. Ms. Carbone has extensive experience in corporate finance transactions, including initial public offerings, SEC-registered equity offerings, investment grade debt offerings, tender offers and venture capital financings, representing both companies and underwriters. She also provides securities law, governance and general corporate advice to various public and private companies. Ms. Carbone’s practice focuses principally on the healthcare industry. From 2000 until 2002, Ms. Carbone practiced in the firm’s San Francisco and Menlo Park offices. Ms. Carbone joined the firm in 1988.
Experience
- Cardinal Health, Inc. in its senior notes offerings
- Cardinal Health, Inc. in its tender offer for senior notes
- Cardinal Health, Inc. in its sale of shares of CareFusion Corporation
- Boston Scientific Corporation in its senior notes offerings
- HeartWare International, Inc. in its common stock and convertible bond offerings
- Photronics, Inc. in its common stock and convertible bond offerings
- Pharmasset, Inc. in its IPO
- GPC Biotech AG in its US IPO and global equity offering
- Ceres Inc. in its Series F Preferred Stock financing
- Caxton Advantage Life Sciences Fund, L.P. in various venture capital investments
- Underwriters in a common stock offering, mandatory convertible preferred stock offering and debt offerings for Schering-Plough
- Underwriters in the IPOs of various biotech and medical device companies, including Acorda Therapeutics, Alnylam Pharmaceuticals, NxStage Medical, Symmetry Medical and Threshold Pharmaceuticals
- Underwriters in the IPO of hhgregg, Inc. and Coldwater Creek Inc.
- Underwriters in public and private financings for a wide range of companies, including HSBC, MasTec, Inland Realty Corporation, Baxter International, Dendreon, Human Genome Sciences, New River Pharmaceuticals, OSI Pharmaceuticals and Oscient Pharmaceuticals
- Advise Audit Committee of Alexander’s, Inc.
Publications
- Author, “Credit Rating Changes Implicating Public Companies”, Insights – The Corporate & Securities Law Advisor, Volume 24 Number 9, September 2010
- Co-Author, “The Cuban Missive Crisis”, The Deal Magazine, August 14, 2009
Bar Admissions/Qualifications
New York
California
|